Crnx stock.

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Tops Revenue Estimates Zacks - Thu May 4, 6:35PM CDT. Crinetics Pharmaceuticals, Inc. (CRNX) delivered earnings and revenue surprises of -3.66% and 325.24%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...Dec 1, 2023 · Key statistics. Crinetics Pharmaceuticals Inc (CRNX:NSQ) set a new 52-week high during today's trading session when it reached 33.20. Over this period, the share price is up 77.74%. Data delayed at least 15 minutes, as of Dec 01 2023 21:00 GMT. Latest Crinetics Pharmaceuticals Inc (CRNX:NSQ) share price with interactive charts, historical ... CENX Latest Pre Market Trades. Select time range to see more trades: Last 100 Trades. Pre-Market Time (ET) Pre-Market Price. Pre-Market Share Volume. 09:30:00. $9.51. View research reports from Argus and trade ideas from Trading Central to understand future stock performances and find high performing trade ideas.Get Our Latest Research Report on CRNX. Crinetics Pharmaceuticals Stock Performance. Shares of CRNX opened at $32.03 on Thursday. Crinetics Pharmaceuticals has a 52-week low of $15.23 and a 52 ...

Century Aluminum Co. is a producer of aluminum and operates aluminum reduction facilities, or smelters, in the United States and Iceland. Its products include standard ingots, T-ingot, extrusion ...According to 8 analysts, the average rating for CRNX stock is "Buy." The 12-month stock price forecast is $44.38, which is an increase of 35.55% from the latest price.Crinetics Pharmaceuticals Inc (CRNX) registered a 2.99% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 2.99% in intraday trading to $32.74 this Friday, 12/01/23, hitting a weekly high. The stock’s 5-day price performance is 2.34%, and it has moved by 10.80% in 30 days.

Price Crinetics Pharmaceuticals, Inc. (CRNX) operates in the biotechnology industry, focusing on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. As of 2023, the company's stock price is $25.60 per share. ... (CRNX) stock closed at $18.45 on June 30, 2023. Product ...In the past month, shares of CRNX have shot up 69.6% against the industry’s 5.9% fall. The surge in the stock price of the company was observed after Crinetics announced meeting the primary ...

Shares of Crinetics Pharmaceuticals, Inc. (CRNX) have gained 9.5% over the past four weeks to close the last trading session at $29.52, but there could still be a solid upside left in the stock if ...Discover historical prices for CENX stock on Yahoo Finance. View daily, weekly or monthly format back to when Century Aluminum Company stock was issued.Read more to see an overview and analysis of CRNX stock. ... The stock currently trades just under $32.00 a share and sports an approximate market capitalization of $2.1 billion.On Sunday, Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) said its Phase 3 PATHFNDR-1 study evaluating paltusotine met the primary and secondary endpoints in acromegaly patients. Acromegaly is a rare ...

Q4 2023 EPS Estimate Trends. Current. -$0.17. 1 Month Ago. -$0.14. 3 Months Ago. $0.05. Century Aluminum Co. analyst estimates, including CENX earnings per share estimates and analyst recommendations.

CRNX stock is up 64% as of Monday morning as some 1.6 million shares change hands. The company’s daily average trading volume is about 493,000 shares. Investors seeking out even more of the most ...

Century Aluminum last released its quarterly earnings data on November 8th, 2023. The industrial products company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.19) by $0.06. The business earned $545.20 million during the quarter, compared to the consensus estimate of $542.30 million.Century Aluminum last released its quarterly earnings data on November 8th, 2023. The industrial products company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.19) by $0.06. The business earned $545.20 million during the quarter, compared to the consensus estimate of $542.30 million.What's Happening With CRNX Stock Today? Crinetics Pharmaceuticals Inc (CRNX) stock is trading at $29.91 as of 11:19 AM on Wednesday, Nov 15, a gain of $1.26, or 4.4% from the previous closing price of $28.65. The stock has traded between $28.47 and $30.15 so far today. Volume today is less active than usual.Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.AVGO. Broadcom Inc. Common Stock. $892.28 UNCH. Find the latest Earnings Report Date for Crinetics Pharmaceuticals, Inc. Common Stock (CRNX) at Nasdaq.com.

CRNX has gained $0.09 from the previous closing price of $28.69 on volume of 163,785 shares. Over the past year the S&P 500 has risen 16.50% while CRNX has gained 57.61%. CRNX lost -$3.41 per share the over the last 12 months. Click Here to get the full Stock Report for Crinetics Pharmaceuticals Inc stock.Crinetics Pharmaceuticals Inc Registered Shs Stock , CRNX 32.03 0.00 0.00% After-market 04:42:01 PM NASJPMorgan Chase & Co. reissued their overweight rating on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) in a research report sent to investors on Monday morning, Benzinga reports. JPMorgan Chase & Co. currently has a $35.00 price target on the stock. A number of other equities research analysts have also …Find real-time CENX - Century Aluminum Co stock quotes, company profile, news and forecasts from CNN Business. Versus Systems (NASDAQ: VS) stock is rising higher on Monday as the business software company’s shares are experiencing heavy trading. Investors in VS stock have likely noticed the rising ...

Higher is usually better. 65.0%. +6.8%. Market Cap. The market value of a company, in total dollars, also called "market capitalization." Market cap is calculated by taking a company's price per ...

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comDec 1, 2023 · Key statistics. Crinetics Pharmaceuticals Inc (CRNX:NSQ) set a new 52-week high during today's trading session when it reached 33.20. Over this period, the share price is up 77.74%. Data delayed at least 15 minutes, as of Dec 01 2023 21:00 GMT. Latest Crinetics Pharmaceuticals Inc (CRNX:NSQ) share price with interactive charts, historical ... Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Friday . The company traded as high as $32.62 and last traded at $32.21, with a volume of 190038 shares trading hands. The stock had previously closed at $30.74. Wall Street Analysts Forecast Growth CRNX has …Find the latest Vortex Brands Co. (VTXB) stock quote, history, news and other vital information to help you with your stock trading and investing.Read more to see an overview and analysis of CRNX stock. ... The stock currently trades just under $32.00 a share and sports an approximate market capitalization of $2.1 billion.Crinetics Pharmaceuticals 's market cap is calculated by multiplying CRNX's current stock price of $29.52 by CRNX's total outstanding shares of 54,686,550.Based on Buys only – 10, in total – the stock claims a Strong Buy consensus rating. Going by the $48 average target, a year from now, shares will be changing hands for a 69% premium. (See CRNX ...

Crinetics Pharmaceuticals (CRNX) has priced an upsized underwritten public offering of 11.44 million shares of its common stock at a price to the public of …

Track Crinetics Pharmaceuticals Inc (CRNX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

VS stock is up 17.2% as of Monday morning. Investors can find more of the most recent stock market news ready to go below! We’ve got all of the hottest stock coverage worth reading about on Monday! A few examples include why shares of Crinetics Pharmaceuticals CRNX stock are rising today, the biggest pre-market stock movers this …BMRN Vs CRNX: Stock comparison by Artificial Intelligence. Which is a better buy? Make smart data-driven investment decisions and get unique insights.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Investors will also note that NUWE is a penny stock. This comes from its low price of $1.92 and market capitalization of $3.579 million. This may help explain some of its volatility today. NUWE ...Shares of Crinetics Pharmaceuticals, Inc. (CRNX) have gained 9.5% over the past four weeks to close the last trading session at $29.52, but there could still be a solid upside left in the stock if ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.For US and Canadian Stocks, the Overview page includes key statistics on the stock's fundamentals, with a link to see more. Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. It is computed by multiplying the market price by the number of outstanding shares. Shares of CRNX are moving higher on heavy trading volume. According to Benzinga Pro, more than 3.2 million shares have already been traded in the session, compared to the stock's 100-day average ...The latest price target for Crinetics Pharmaceuticals ( NASDAQ: CRNX) was reported by JP Morgan on Monday, November 20, 2023. The analyst firm set a price target for 35.00 expecting CRNX to rise ...

Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) stock is surging today, last seen up 72.7% to trade at $27.58 at last check, after the late stage trial for its experimental drug paltusotine to treat a ...Nov 30, 2023 · Get a real-time Century Aluminum Company (CENX) stock price quote with breaking news, financials, statistics, charts and more. The stock opened at $30.37, slightly higher than the previous close of $29.97. Throughout the day, the stock reached a high of $31.21 and a low of $30.11. The trading volume for the day was 9,630 shares. CRNX, also known as IDYA Biosciences Inc., operates in the health technology sector, specifically in the major pharmaceuticals industry.Nov 21, 2023 · Crinetics granted non-qualified stock option awards to purchase an aggregate of 83,600 shares of its common stock to four new non-executive employees Pipeline We support patients, endocrinologists, and healthcare providers by finding better therapies for endocrine diseases and endocrine oncology such as: Instagram:https://instagram. mutf vsmaxwhy is cybin stock droppinggood phone insurancemanchester united stocks See the company profile for Crinetics Pharmaceuticals, Inc. (CRNX) including business summary, industry/sector information, number of employees, business summary, … wallstreetbets stocks listarrived homes vs fundrise News Releases. Year. 2023. November 21, 2023. Viridian Therapeutics to Participate in 6th Annual Evercore ISI HealthCONx Conference. November 13, 2023. Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update. November 8, 2023. Viridian Therapeutics to Participate in the Jefferies London Healthcare ... retailmenot athleta CRNX. Nasdaq Global Select Market. Indicate by check mark whether the registrant is an ... In exchange, Crinetics received 50,500,000 shares of common stock of ...Get Our Latest Research Report on CRNX. Crinetics Pharmaceuticals Stock Performance. Shares of CRNX opened at $32.03 on Thursday. Crinetics Pharmaceuticals has a 52-week low of $15.23 and a 52 ...